Medipharm Labs Corp (LABS) — Financial Flexibility Index
Medipharm Labs Corp (LABS) has a Financial Flexibility Index of -0.09x as of March 2026. Free cash flow of CA$-777.00K (operating CF CA$-778.00K minus capex CA$1.00K) represents 0% of total liabilities (CA$8.52 Million). Check LABS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medipharm Labs Corp Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Medipharm Labs Corp across 10 annual periods. For the full cash flow conversion analysis, see LABS operating cash flow.
Annual Financial Flexibility Index for Medipharm Labs Corp (2016–2025)
Year-by-year free cash flow to debt coverage for Medipharm Labs Corp. Explore LABS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.54x | CA$-5.40 Million | CA$-5.50 Million | CA$9.93 Million | ▼ -22.0% |
| 2024 | -0.45x | CA$-4.71 Million | CA$-4.86 Million | CA$10.55 Million | ▲ +58.9% |
| 2023 | -1.09x | CA$-11.87 Million | CA$-12.34 Million | CA$10.93 Million | ▲ +32.2% |
| 2022 | -1.60x | CA$-15.21 Million | CA$-16.07 Million | CA$9.49 Million | ▼ -18.8% |
| 2021 | -1.35x | CA$-12.43 Million | CA$-13.21 Million | CA$9.21 Million | ▼ -77.4% |
| 2020 | -0.76x | CA$-30.27 Million | CA$-37.77 Million | CA$39.82 Million | ▼ -498.5% |
| 2019 | 0.19x | CA$7.17 Million | CA$-25.27 Million | CA$37.60 Million | ▼ -17.9% |
| 2018 | 0.23x | CA$3.46 Million | CA$-11.11 Million | CA$14.89 Million | ▼ -74.6% |
| 2017 | 0.92x | CA$2.31 Million | CA$166.00K | CA$2.52 Million | ▼ -98.0% |
| 2016 | 44.71x | CA$2.09 Million | CA$-54.69K | CA$46.73K | — |